The antigenic maps will be published with open access to the public. The synthetic hemagglutinin constructs, reverse genetics viruses and antisera will be shared with the laboratories that contributed the genome sequence data to GISAID. Reagents may also be provided to other researchers, including National Influenza Centers and global reference laboratories, upon assurance that the originating laboratory, where the clinical specimen or virus isolate was first obtained, and the submitting laboratory, where sequence data have been generated and submitted through the GISAID mechanism, are fully recognized, to ensure fair attribution of contributions to the results benefitting from the data.
The investigators wish to thank the governments and scientists of Cambodia, China, Egypt, Ghana, Indonesia, Nepal, Russia, Vietnam for their contributions that made this research possible.
For further information please visit:
Centre for Pathogen Evolution at the University of Cambridge
Molecular Virology and Virus Evolution at the Erasmus Medical Center in Rotterdam
School of Veterinary Medicine at the University of Wisconsin